Intranasal epidermal growth factor treatment rescues neonatal brain injury
Open Access
- 25 December 2013
- journal article
- research article
- Published by Springer Nature in Nature
- Vol. 506 (7487) , 230-234
Abstract
Diffuse white matter injury is common in very preterm infants; here, enhanced epidermal growth factor receptor signalling in oligodendrocyte precursor cells in a mouse model of such injury is shown to increase cellular and functional recovery. As the survival rates of premature babies have increased, so too has the incidence of chronic neurodevelopmental disorders in neonates. Diffuse white matter injury is common in preterm infants with neonatal brain injury and is partially the result of a failure in oligodendrocyte precursor cell maturation. Here, Vittorio Gallo and colleagues specifically enhanced epidermal growth factor receptor (EGFR) signalling in oligodendrocyte precursor cells in a model of diffuse white matter injury and found increased cellular and functional recovery post-injury. Oligodendrocyte cell death was decreased and the generation of new oligos was increased by the treatment. This identifies EGFR signalling as a potential therapeutic target in the treatment of premature children after white matter injury. There are no clinically relevant treatments available that improve function in the growing population of very preterm infants (less than 32 weeks’ gestation) with neonatal brain injury. Diffuse white matter injury (DWMI) is a common finding in these children and results in chronic neurodevelopmental impairments1,2. As shown recently, failure in oligodendrocyte progenitor cell maturation contributes to DWMI3. We demonstrated previously that the epidermal growth factor receptor (EGFR) has an important role in oligodendrocyte development4. Here we examine whether enhanced EGFR signalling stimulates the endogenous response of EGFR-expressing progenitor cells during a critical period after brain injury, and promotes cellular and behavioural recovery in the developing brain. Using an established mouse model of very preterm brain injury, we demonstrate that selective overexpression of human EGFR in oligodendrocyte lineage cells or the administration of intranasal heparin-binding EGF immediately after injury decreases oligodendroglia death, enhances generation of new oligodendrocytes from progenitor cells and promotes functional recovery. Furthermore, these interventions diminish ultrastructural abnormalities and alleviate behavioural deficits on white-matter-specific paradigms. Inhibition of EGFR signalling with a molecularly targeted agent used for cancer therapy demonstrates that EGFR activation is an important contributor to oligodendrocyte regeneration and functional recovery after DWMI. Thus, our study provides direct evidence that targeting EGFR in oligodendrocyte progenitor cells at a specific time after injury is clinically feasible and potentially applicable to the treatment of premature children with white matter injury.Keywords
This publication has 48 references indexed in Scilit:
- Fibroblast growth factor 1 (FGFR1) modulation regulates repair capacity of oligodendrocyte progenitor cells following chronic demyelinationNeurobiology of Disease, 2012
- Neuroanatomical changes in a mouse model of early life neglectBrain Structure and Function, 2011
- Arrested preoligodendrocyte maturation contributes to myelination failure in premature infantsAnnals of Neurology, 2011
- Asymmetry-Defective Oligodendrocyte Progenitors Are Glioma PrecursorsCancer Cell, 2011
- NG2+ CNS Glial Progenitors Remain Committed to the Oligodendrocyte Lineage in Postnatal Life and following NeurodegenerationNeuron, 2010
- Notch and EGFR pathway interaction regulates neural stem cell number and self-renewalNature, 2010
- Modeling premature brain injury and recoveryInternational Journal of Developmental Neuroscience, 2009
- Cuprizone Demyelination of the Corpus Callosum in Mice Correlates with Altered Social Interaction and Impaired Bilateral Sensorimotor CoordinationASN Neuro, 2009
- Differential Notch signalling distinguishes neural stem cells from intermediate progenitorsNature, 2007
- Acute Plasmalemma Permeability and Protracted Clearance of Injured Cells after Controlled Cortical Impact in MiceJournal of Cerebral Blood Flow & Metabolism, 2007